previous compound ID: 1134 next compound
InChIKey: JZFPYUNJRRFVQU-UHFFFAOYSA-N
SMILES: C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "R Robert" "E Matthes" "J Liao" "GW Carlile" "J Goepp" "DY Thomas" "D Rotin" "B Kus" "JW Hanrahan"

chemical graph of compound 1134





CID is 4488
synonyms found at PubChem are:
niflumic acid, 4394-00-7, Nifluril, Landruma, Forenol, Actol, Acido niflumico, Nifluminic acid, Acide niflumique, Acidum niflumicum, Acide niflumique [INN-French], Acido niflumico [INN-Spanish], Acidum niflumicum [INN-Latin], Donalgin, Niflumate, 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid, Acide niflumique [French], Acido niflumico [Italian], UP 83, 2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid, 2-(3-(Trifluoromethyl)anilino)nicotinic acid, 2-[3-(Trifluoromethyl)anilino]nicotinic acid, Niflamol, Niflam, Lopac-N-0630, 2-(3-Trifluoromethylanilino)nicotinic Acid, UNII-4U5MP5IUD8, Niflumic acid [INN:DCF], Niflugel (TN), SC 1332, CCRIS 5740, 3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, Niflumic acid (INN), 2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid, 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid, EINECS 224-516-2, 2-(3-Trifluoromethyl-phenylamino)-nicotinic acid, BRN 0489360, 4U5MP5IUD8, MLS000069713, 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID, NFL, CHEBI:34888, 3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino [French], JZFPYUNJRRFVQU-UHFFFAOYSA-N, 2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID, 2-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid, Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino, 2-[alpha,alpha,alpha-trifluoro-m-toluidino]-nicotinic acid, NCGC00015724-10, SMR000058199, CAS-4394-00-7, DSSTox_CID_3368, 2-(3-[Trifluoromethyl]anilino)nicotinic acid, N 0630, DSSTox_RID_76996, 2-(3-(Trifluoromethyl)phenylamino)nicotinic acid, 2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid, DSSTox_GSID_23368, 2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid, Nicotinic acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-, Niflactol, Niflugel, Flunir, Acid, Niflumic, SR-01000000231, 2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid, NiflumicAcid, ni-flumic acid, Niflumic acid [INN:BAN:DCF], Actol, analgesic, Prestwick_890, PubChem21796, Spectrum_001353, 1td7, ACMC-209jvx, Opera_ID_1746, Prestwick0_000255, Prestwick1_000255, Prestwick2_000255, Prestwick3_000255, Spectrum2_000794, Spectrum3_001485, Spectrum4_000043, Spectrum5_001216, Niflumic acid (Hit 16), D00HGB, AC1L1IA4, CBiol_001828, Lopac0_000845, SCHEMBL24706, BSPBio_000070, BSPBio_001393, BSPBio_003069, KBioGR_000113, KBioGR_000505, KBioSS_000113, KBioSS_001833, 5-22-13-00598 (Beilstein Handbook Reference), KSC587Q8N, MLS001076327, CHEMBL63323, DivK1c_000277, SPECTRUM1502015, SPBio_000928, SPBio_002289, BPBio1_000078, GTPL2439, DTXSID1023368, UPSA Brand 1 of Niflumic Acid, UPSA Brand 2 of Niflumic Acid, BDBM85507, CTK4I7886, HMS500N19, KBio1_000277, KBio2_000113, KBio2_001833, KBio2_002681, KBio2_004401, KBio2_005249, KBio2_006969, KBio3_000225, KBio3_000226, KBio3_002569, MolPort-000-140-647, NINDS_000277, Upsamedica Brand of Niflumic Acid, Bio1_000114, Bio1_000603, Bio1_001092, Bio2_000113, Bio2_000593, HMS1361F15, HMS1568D12, HMS1791F15, HMS1921D12, HMS1989F15, HMS2090D19, HMS2095D12, HMS2234F11, HMS3262J11, HMS3374H01, HMS3402F15, HMS3649A08, HMS3656P14, HMS3712D12, Pharmakon1600-01502015, UP-83, ZINC125031, HY-B0493, KS-00000CB5, NSC_4488, Tox21_110206, Tox21_500845, ANW-30043, BBL003619, CCG-40157, DL-457, MFCD00010569, Nicotinic acid, 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)-, NSC758196, s3018, SBB001146, STK803109, UPSA Conseil Brand of Niflumic Acid, AKOS000519590, Tox21_110206_1, AC-2652, CS-2614, DB04552, GS-3202, LP00845, MCULE-3027710274, NSC-758196, RTR-017015, IDI1_000277, IDI1_033863, NCGC00015724-01, NCGC00015724-02, NCGC00015724-03, NCGC00015724-04, NCGC00015724-05, NCGC00015724-06, NCGC00015724-07, NCGC00015724-08, NCGC00015724-09, NCGC00015724-11, NCGC00015724-12, NCGC00015724-13, NCGC00015724-14, NCGC00015724-17, NCGC00023636-03, NCGC00023636-04, NCGC00023636-05, NCGC00023636-06, NCGC00023636-07, NCGC00023636-08, NCGC00023636-09, NCGC00261530-01, AJ-11904, AN-13743, BAS 00821161, BC218927, BR-72979, LS-96639, ST013871, CAS_4394-00-7, SBI-0050821.P003, 2(3'-trifluormethylanilino)-nicotinic acid, AB0012229, AB1004097, 2-(3-(Trifluoromethyl)anilino)nicotinicacid, AB00052255, AM20070143, EU-0100845, FT-0603659, ST24027408, T7852, 2-(A,A,A-Trifluoro-m-toluidino)nicotinic acid, 39690A, C13698, D08275, S00109, AB00052255-17, AB00052255_18, AB00052255_19, 394N007, SR-01000000231-2, SR-01000000231-5, SR-01000000231-6, W-106215, BRD-K98763141-001-04-3, BRD-K98763141-001-06-8, BRD-K98763141-001-17-5, SR-01000000231-11, 2-[3-(Trifluoromethyl)anilino]-3-pyridinecarboxylic acid, Niflumic acid, European Pharmacopoeia (EP) Reference Standard, 2-{[3-(trifluoromethyl)-phenyl]-amino}-3-pyridincarboxylic acid, 2-[3-(Trifluoromethyl)anilino]nicotinic acid; 2-(|A,|A,|A-Trifluoro-m-toluidino)nicotinic acid